甲基-(2-甲基-辛基)-醚 | 857825-39-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 甲基-(2-甲基-辛基)-醚
• 英文名称: methyl-(2-methyl-octyl)-ether
• 英文别名: Methyl-(2-methyl-octyl)-aether；1-Methoxy-2-methyl-octan；Methyl 2-methyloctyl ether；1-methoxy-2-methyloctane
• CAS: 857825-39-9
• 化学式: C₁₀H₂₂O
• 分子量: 158.284
• InChiKey: DFETWRCIAGXRCO-UHFFFAOYSA-N

物化性质

• 沸点：
  175.7±8.0 °C(Predicted)
• 密度：
  0.790±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  11
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  甲基-(2-甲基-辛基)-醚 在 氢溴酸 作用下， 生成 1-溴-2-甲基辛烷
  参考文献：
  名称：

  Gredy, Bulletin de la Societe Chimique de France, 1935, vol. <5> 2, p. 1029,1033

  摘要：

  DOI：
• 作为产物：
  描述：

  氯甲基甲基醚 、 2-溴辛烷 生成 甲基-(2-甲基-辛基)-醚
  参考文献：
  名称：

  Gredy, Bulletin de la Societe Chimique de France, 1935, vol. <5> 2, p. 1029,1033

  摘要：

  DOI：

文献信息

• [EN] QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS<br/>[FR] COMPOSÉS CONTENANT DE LA QUINOXALINE EN TANT QU'INHIBITEURS DU VIRUS DE L'HÉPATITE C
  申请人：ENANTA PHARM INC

  公开号：WO2009064975A1

  公开（公告）日：2009-05-22

  The present invention discloses compounds of formula I and II or pharmaceutically acceptable salts, esters, or prodrugs thereof which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

  本发明公开了抑制丝氨酸蛋白酶活性的I和II公式化合物，或其药物可接受的盐、酯或前药，尤其是抑制丙型肝炎病毒（HCV）NS3-NS4A蛋白酶的活性。因此，本发明的化合物干扰丙型肝炎病毒的生命周期，并且也用作抗病毒剂。本发明进一步涉及包含前述化合物的药物组合物，用于给患有HCV感染的主体进行管理。本发明还涉及通过管理包含本发明化合物的药物组合物来治疗主体中的HCV感染的方法。
• Method for the production of beta-ketonitriles
  申请人：Vogelbacher Uwe Josef

  公开号：US20100105903A1

  公开（公告）日：2010-04-29

  The present invention relates to a process for preparing β-ketonitriles of the general formula I in which R 1 is, inter alia, C 1 -C 12 -alkyl, C 2 -C 12 -alkenyl, C 2 -C 12 -alkinyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkyl-C 1 -C 4 -alkyl, phenyl-C 1 -C 4 -alkyl, phenoxy-C 1 -C 4 -alkyl or benzyloxy-C 1 -C 4 -alkyl; R 2 is, inter alia, hydrogen, C 1 -C 12 -alkyl, C 2 -C 12 -alkenyl, C 2 -C 12 -alkinyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkyl-C 1 -C 4 -alkyl, phenyl, phenyl-C 1 -C 4 -alkyl, phenoxy-C 1 -C 4 -alkyl or benzyloxy-C 1 -C 4 -alkyl, which comprises reacting a nitrile of the formula II in which R 1 has one of the meanings given above with a carboxylic ester of the formula III in which R 2 has one of the meanings given above and R 3 is C 1 -C 12 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkyl-C 1 -C 4 -alkyl, phenyl-C 1 -C 4 -alkyl, phenoxy-C 1 -C 4 -alkyl or benzyloxy-C 1 -C 4 -alkyl, where the reaction is carried out in the presence of a potassium alkoxide and at least 80% of the nitrile of the formula II are added to the reaction under reaction conditions.

  本发明涉及一种制备一般式I的β-酮腈的方法，其中R1是C1-C12-烷基、C2-C12-烯基、C2-C12-炔基、C3-C8-环烷基、C3-C8-环烷基-C1-C4-烷基、苯基-C1-C4-烷基、苯氧基-C1-C4-烷基或苄氧基-C1-C4-烷基；R2是氢、C1-C12-烷基、C2-C12-烯基、C2-C12-炔基、C3-C8-环烷基、C3-C8-环烷基-C1-C4-烷基、苯基、苯基-C1-C4-烷基、苯氧基-C1-C4-烷基或苄氧基-C1-C4-烷基。该方法包括将具有上述给定含义之一的一般式II的腈与具有上述给定含义之一的一般式III的羧酸酯反应，其中R3是C1-C12-烷基、C1-C4-烷氧基-C1-C4-烷基、C3-C8-环烷基、C3-C8-环烷基-C1-C4-烷基、苯基-C1-C4-烷基、苯氧基-C1-C4-烷基或苄氧基-C1-C4-烷基，在存在钾醇和至少80%的一般式II的腈被加入到反应中，并在反应条件下进行。
• THIAZOLOTHIAZOLE DERIVATIVE
  申请人：HORIBA Koji

  公开号：US20100137611A1

  公开（公告）日：2010-06-03

  A thiazolothiazole derivative is represented by the following Formula (I). In Formula (I), each R 1 independently represents a straight chain alkyl group having 3 to 20 carbon atoms, a straight chain alkoxy group having 3 to 20 carbon atoms, a branched alkyl group having 3 to 20 carbon atoms, or a branched alkoxy group having 3 to 20 carbon atoms; and each R 2 independently represents a hydrogen atom, a straight chain alkyl group having 1 to 20 carbon atoms, a straight chain alkoxy group having 1 to 20 carbon atoms, a branched alkyl group having 3 to 20 carbon atoms, or a branched alkoxy group having 3 to 20 carbon atoms.

  一种噻唑噻唑衍生物由以下化学式（I）表示。在化学式（I）中，每个R1独立地代表具有3到20个碳原子的直链烷基基团，具有3到20个碳原子的直链烷氧基团，具有3到20个碳原子的支链烷基基团，或具有3到20个碳原子的支链烷氧基团；每个R2独立地代表氢原子，具有1到20个碳原子的直链烷基基团，具有1到20个碳原子的直链烷氧基团，具有3到20个碳原子的支链烷基基团，或具有3到20个碳原子的支链烷氧基团。
• ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY MEDIUM
  申请人：IMAI Akira

  公开号：US20100276672A1

  公开（公告）日：2010-11-04

  An organic electroluminescent device includes: a pair of electrodes including a positive electrode and a negative electrode, at least one of the electrodes being transparent or semi-transparent; and an organic compound layer including one or more layers interposed between the pair of electrodes, at least one layer included in the organic compound layer containing one or more compounds represented by the following formula (I): in formula (I), R 1 s each independently representing a linear alkyl, linear alkoxy, branched alkyl, or branched alkoxy group having from 3 to 20 carbon atoms; and R 2 s each independently representing a hydrogen atom, a linear alkyl group having from 1 to 20 carbon atoms, a linear alkoxy group having from 1 to 20 carbon atoms, a branched alkyl group having from 3 to 20 carbon atoms, or a branched alkoxy group having from 3 to 20 carbon atoms.

  一种有机电致发光器件包括：一对电极，包括一个正电极和一个负电极，其中至少一个电极是透明或半透明的；以及一个有机化合物层，包括夹在一对电极之间的一个或多个层，有机化合物层中至少包含一个含有一个或多个以下式(I)所代表的化合物的层：在式(I)中，R1分别独立地表示具有3至20个碳原子的直链烷基，直链烷氧基，支链烷基或支链烷氧基；R2分别独立地表示氢原子，具有1至20个碳原子的直链烷基，具有1至20个碳原子的直链烷氧基，具有3至20个碳原子的支链烷基，或具有3至20个碳原子的支链烷氧基。
• THIAZOLOTHIAZOLE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING THE SAME
  申请人：Fuji Xerox Co., Ltd.

  公开号：EP2233488A1

  公开（公告）日：2010-09-29

  A thiazolothiazole derivative is represented by the following Formula (I). In Formula (I), each R1 independently represents a straight chain alkyl group having 3 to 20 carbon atoms, a straight chain alkoxy group having 3 to 20 carbon atoms, a branched alkyl group having 3 to 20 carbon atoms, or a branched alkoxy group having 3 to 20 carbon atoms; and each R2 independently represents a hydrogen atom, a straight chain alkyl group having 1 to 20 carbon atoms, a straight chain alkoxy group having 1 to 20 carbon atoms, a branched alkyl group having 3 to 20 carbon atoms, or a branched alkoxy group having 3 to 20 carbon atoms.

  噻唑噻唑衍生物由下式(I)表示。在式（I）中，每个 R1 独立地代表具有 3 至 20 个碳原子的直链烷基、具有 3 至 20 个碳原子的直链烷氧基、具有 3 至 20 个碳原子的支链烷基或具有 3 至 20 个碳原子的支链烷氧基；每个 R2 独立地代表氢原子、具有 1 至 20 个碳原子的直链烷基、具有 1 至 20 个碳原子的直链烷氧基、具有 3 至 20 个碳原子的支链烷基或具有 3 至 20 个碳原子的支链烷氧基。